miércoles, 22 de julio de 2026

GLP-1 Use Linked To Fewer Long-Term Sick Days From Work, Study Finds

GLP-1 Use Linked To Fewer Long-Term Sick Days From Work, Study Finds According to a study by the National Bureau of Economic Research, researchers noted a 17% decrease in long-term sick leave among Danish workers who used GLP-1s compared with those who didn't use the medications. Also: Novo Nordisk sues Eli Lilly; and more. https://kffhealthnews.org/morning-breakout/public-health-072226/

No hay comentarios: